147 related articles for article (PubMed ID: 24475135)
1. Evaluating the potential bioactivity of a novel compound ER1626.
Wang L; Zeng Y; Wang T; Liu H; Xiao H; Xiang H
PLoS One; 2014; 9(1):e86509. PubMed ID: 24475135
[TBL] [Abstract][Full Text] [Related]
2. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
3. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Zulfadli AJ; Omar AR; Sulaiman MR; Abdullah MP; Alitheen NB
PLoS One; 2014; 9(10):e105244. PubMed ID: 25286005
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
Zhang X; Mukerji R; Samadi AK; Cohen MS
BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
[TBL] [Abstract][Full Text] [Related]
5. 2-Methylpyridine-1-ium-1-sulfonate from Allium hirtifolium: An anti-angiogenic compound which inhibits growth of MCF-7 and MDA-MB-231 cells through cell cycle arrest and apoptosis induction.
Mohammadi-Motlagh HR; Shokohinia Y; Mojarrab M; Rasouli H; Mostafaie A
Biomed Pharmacother; 2017 Sep; 93():117-129. PubMed ID: 28624423
[TBL] [Abstract][Full Text] [Related]
6. Anticancer and anti-angiogenic activities of extract from Actinidia eriantha Benth root.
Wu JG; Ma L; Lin SH; Wu YB; Yi J; Yang BJ; Wu JZ; Wong KH
J Ethnopharmacol; 2017 May; 203():1-10. PubMed ID: 28323051
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer amelioration by Butea monosperma in-vitro and in-vivo.
Karia P; Patel KV; Rathod SSP
J Ethnopharmacol; 2018 May; 217():54-62. PubMed ID: 29366766
[TBL] [Abstract][Full Text] [Related]
8. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
M HR; Ghosh D; Banerjee R; Salimath BP
Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
[TBL] [Abstract][Full Text] [Related]
9. PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells.
Luo J; Soh JW; Xing WQ; Mao Y; Matsuno T; Weinstein IB
Anticancer Res; 2001; 21(3B):1665-71. PubMed ID: 11497245
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
12. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
13. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.
Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T
Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811
[TBL] [Abstract][Full Text] [Related]
14. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
Sun Y; Wang C; Yang H; Ma X
Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
[TBL] [Abstract][Full Text] [Related]
15. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
[TBL] [Abstract][Full Text] [Related]
16. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.
Wang W; Rayburn ER; Velu SE; Chen D; Nadkarni DH; Murugesan S; Chen D; Zhang R
Breast Cancer Res Treat; 2010 Sep; 123(2):321-31. PubMed ID: 19936915
[TBL] [Abstract][Full Text] [Related]
17. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Abdullah MP; Ho CL; Omar AR; Ismail J; Alitheen NB
BMC Complement Altern Med; 2016 Feb; 16():86. PubMed ID: 26922065
[TBL] [Abstract][Full Text] [Related]
18. [Effects of proteasome inhibitor MG132 on cell proliferation, apoptosis, and cell cycle in HEC-1B and Ishikawa cells].
Zhang Q; Huang J; Li DQ; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):830-3, 838. PubMed ID: 23387207
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents.
Tang Z; Wu C; Wang T; Lao K; Wang Y; Liu L; Muyaba M; Xu P; He C; Luo G; Qian Z; Niu S; Wang L; Wang Y; Xiao H; You Q; Xiang H
Eur J Med Chem; 2016 Aug; 118():328-39. PubMed ID: 27176944
[TBL] [Abstract][Full Text] [Related]
20. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
Liu XH; Zheng XF; Wang YL
Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
